KRISTEN MITCHEM: Open Payments
NPI 1932956141 · MILTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,787 in 95 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $705 · 2025 $1,787
Food & beverage: $1,683Education: $104
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 26 | $377 |
| Otsuka America Pharmaceutical, Inc. | 17 | $237 |
| Neurocrine BioSciences, Inc. | 6 | $205 |
| Vanda Pharmaceuticals Inc. | 6 | $181 |
| E.R. Squibb & Sons, L.L.C. | 9 | $161 |
| Lundbeck LLC | 6 | $131 |
| Corium, LLC | 5 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $99 |
| ABBVIE INC. | 4 | $73 |
| Alkermes, Inc. | 3 | $66 |
Products named: REXULTI, AUSTEDO XR, INGREZZA, COBENFY, FANAPT, Azstarys, CAPLYTA, VRAYLAR.
Industry payments across FL — which companies pay providers there.
